© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Estrone stands out as one of the three major naturally occurring estrogens in the human body. Chemically, it goes by the formula C18H22O2 and reveals itself under the CAS number 53-16-7. Its molecular structure brings together eighteen carbon atoms, twenty-two hydrogens, and two oxygens in a crystalline framework. Most sources describe this substance as a white to off-white, odorless solid, presenting itself as either crystalline flakes, fine powder, or compact granules, depending on how it's processed and stored. For those who work in the lab, these forms allow for a range of experiments from medical research to industrial applications.
When held up to the light, estrone sits as a translucent crystal with a melting point between 254 and 256 °C, a property that puts it ahead of many natural estrogens used in bulk. This high melting point not only supports transportation and storage but also speaks to its stability. The density, measured at about 1.24 g/cm3, means it doesn't float in water but mixes best with organic solvents like acetone, ethanol, or chloroform. Estrone does not dissolve well in water—scientists measure this solubility at just 0.007 mg/mL—so nearly all estrone-based solutions rely on alcohol or other stronger solvents. In laboratories, extracting or purifying estrone often requires careful control of temperature and pH due to this limited solubility.
Structurally, estrone's backbone fits the classic steroid ring system with a single aromatic A ring. This ring structure gives estrone both strength and specificity in its interactions with other molecules, especially within human tissue. Looking closer, this compound carries a ketone functional group at position 17, distinguishing it from other estrogens such as estradiol. This difference changes both the way it binds in the body and its use in synthesis. For those working in material sciences or the pharmaceutical sector, knowing these subtle differences can mean better results in custom blends or enhanced medical products.
The chemical gets shipped, traded, and regulated globally with a dedicated HS Code: 293723. This code identifies it among the family of steroidal hormones, making it easier for customs officials and shipping companies handling regulatory paperwork. Manufacturers supply estrone in several grades, from research quality to pharmaceutical grade, with purity levels often exceeding 98%. Assay tests confirm these levels, sometimes using high-performance liquid chromatography (HPLC) or gas chromatography-mass spectrometry (GC-MS) to rule out trace impurities. The presence of even tiny contaminants can seriously affect performance, especially in high-stakes medical applications.
Estrone is not your average household chemical. It brings benefits but also risks. In the workplace, improper handling has caused harm—long-term exposure links to cancer risks and reproductive issues. Material safety data sheets (MSDS) rank it as harmful, not just for acute exposure but over periods of sustained contact or inhalation. Gloves, lab coats, eye shields, and adequate air flow are not optional for those working with raw estrone or its derivatives. Spills or skin contact call for immediate cleanup, often with water and soap or using designated chemical spill kits. Storage asks for dry, tightly sealed, and cool conditions, often in specially marked containers away from incompatible substances. Ignoring these precautions not only puts workers at risk but can result in heavy regulatory consequences.
Estrone's status as both a vital hormone and a key raw material for synthesized estrogens makes it a focus point in various industries. Medical researchers use estrone for hormone replacement therapies, while others tap its molecular base for synthesizing other important compounds. As a raw resource, estrone must be both consistent and free of disruptive impurities so that finished pharmaceutical products work as promised. Spotty quality or supply chain interruptions have triggered shortages in the past, affecting not only labs but also end-users relying on consistent results. The high standards required by regulatory authorities like the FDA and EMA drive manufacturers to adopt strict quality controls, but unexpected contamination or storage failures still pose risks. To keep quality levels high, suppliers use extensive in-house and third-party testing, including molecular fingerprinting and batch-to-batch comparison, to prevent faulty shipments from reaching consumers.
Addressing the risks that come with estrone starts with strong education and oversight. Companies and labs need regular training on chemical hygiene and emergency response, reducing the chance of costly accidents or long-term health consequences. For manufacturers and distributors, strict batch tracking and documentation make it possible to recall tainted supplies before they enter the production stream. Advances in traceability technology, like barcode scanning or blockchain-based records, have made a noticeable difference by closing gaps in supply chain security. In the case of handling rare or hazardous compounds like estrone, open communication with customs, shipping partners, and regulators improves compliance and shortens delivery times. Adopting sustainable production practices, such as greener extraction methods or solvent recycling, builds not just safety but public trust. As regulations adjust to reflect new findings on hormone safety, those who prioritize transparency and safety will lead the way in this competitive field.
